Synthesis, characterization and phytobiological evaluation of new 2-[4-(4-bromophenylsulfonyl)phenyl]- 4-methyloxazol-5(4h)-one and some new 5-aryl-2-[4-(4-bromophenylsulfonyl)phenyl]-4-methyloxazoles
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
713 8
Ultima descărcare din IBN:
2021-12-22 19:10
Căutarea după subiecte
similare conform CZU
615.322 (214)
Medicamentele potrivit originii lor (470)
SM ISO690:2012
APOSTOL, Theodora-Venera, SOCEA, Laura-Ileana, BARBUCEANU, Stefania-Felicia, SARAMET, Ioana, OLARU, Octavian-Tudorel, DRAGHICI, Constantin C.. Synthesis, characterization and phytobiological evaluation of new 2-[4-(4-bromophenylsulfonyl)phenyl]- 4-methyloxazol-5(4h)-one and some new 5-aryl-2-[4-(4-bromophenylsulfonyl)phenyl]-4-methyloxazoles . In: Revista Farmaceutică a Moldovei , 2014, nr. 3-4, p. 45. ISSN 1812-5077.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Revista Farmaceutică a Moldovei
Numărul 3-4 / 2014 / ISSN 1812-5077

Synthesis, characterization and phytobiological evaluation of new 2-[4-(4-bromophenylsulfonyl)phenyl]- 4-methyloxazol-5(4h)-one and some new 5-aryl-2-[4-(4-bromophenylsulfonyl)phenyl]-4-methyloxazoles
CZU: 615.322

Pag. 45-45

Apostol Theodora-Venera1, Socea Laura-Ileana1, Barbuceanu Stefania-Felicia1, Saramet Ioana1, Olaru Octavian-Tudorel1, Draghici Constantin C.2
 
1 University of Medicine and Pharmacy “Carol Davilla”, Bucharest,
2 "C.D. Nenitzescu" Centre of Organic Chemistry, Romanian Academy
 
Disponibil în IBN: 5 ianuarie 2016


Rezumat

Heterocyclic compounds containing 1,3-oxazol-5(4H)-one and 1,3-oxazole ring are important targets in synthetic and medicinal chemistry, because of their applications as potentially active compounds. Thus, some 1,3-oxazol-5(4H)-ones have been reported to present antimicrobial and antitumor activity. 1,3-Oxazoles are frequent substructures in various biologically active compounds used in therapeutics as anti-inflammatory (e.g. Oxaprozin, Romazarit, Ditazol, Isamoxole), analgesic (e.g. Oxaprozin), antibacterial, antifungal (e.g. Sulfamoxole, Sulfaguanole), muscle relaxant (e.g. Azumolene) drugs. Therefore, there is considerable interest to synthesize new 1,3-oxazole5(4H)-ones and 1,3-oxazoles which contain 4-(4-bromophenylsulfonyl) phenyl moiety in 2 position with a hope to obtain potent biologically active compounds. The plant growth regulatory effects of the new compounds were examined.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-41644</cfResPublId>
<cfResPublDate>2014-12-11</cfResPublDate>
<cfIssue>3-4</cfIssue>
<cfStartPage>45</cfStartPage>
<cfISSN>1812-5077</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/41644</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>Synthesis, characterization and phytobiological evaluation of new 2-[4-(4-bromophenylsulfonyl)phenyl]-
4-methyloxazol-5(4h)-one and some new 5-aryl-2-[4-(4-bromophenylsulfonyl)phenyl]-4-methyloxazoles
</cfTitle>
<cfAbstr cfLangCode='EN' cfTrans='o'>Heterocyclic compounds containing 1,3-oxazol-5(4H)-one and 1,3-oxazole ring are important targets in synthetic and medicinal chemistry, because of their applications as potentially active compounds. Thus, some 1,3-oxazol-5(4H)-ones have been reported to present antimicrobial and antitumor activity. 1,3-Oxazoles are frequent substructures in various biologically active compounds used in therapeutics as anti-inflammatory (e.g. Oxaprozin, Romazarit, Ditazol, Isamoxole), analgesic (e.g. Oxaprozin), antibacterial, antifungal (e.g. Sulfamoxole, Sulfaguanole), muscle relaxant (e.g. Azumolene) drugs. Therefore, there is considerable interest to synthesize new 1,3-oxazole5(4H)-ones and 1,3-oxazoles which contain 4-(4-bromophenylsulfonyl) phenyl moiety in 2 position with a hope to obtain potent biologically active compounds. The plant growth regulatory effects of the new compounds were examined. </cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-53268</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-53269</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-53270</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-53271</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-45697</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-53272</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-53268</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-53268-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
<cfFamilyNames>Apostol</cfFamilyNames>
<cfFirstNames>Theodora-Venera</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-53269</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-53269-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
<cfFamilyNames>Socea</cfFamilyNames>
<cfFirstNames>Laura-Ileana</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-53270</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-53270-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
<cfFamilyNames>Barbuceanu</cfFamilyNames>
<cfFirstNames>Stefania-Felicia</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-53271</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-53271-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
<cfFamilyNames>Saramet</cfFamilyNames>
<cfFirstNames>Ioana</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-45697</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-45697-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
<cfFamilyNames>Olaru</cfFamilyNames>
<cfFirstNames>Octavian-Tudorel</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-53272</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-53272-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2014-12-11T24:00:00</cfStartDate>
<cfFamilyNames>Draghici</cfFamilyNames>
<cfFirstNames>Constantin C.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>